Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens

Vaccine

Volumn 22, Issue 7, 2004, Pages 898-908

  Braun, Jan M ^a,b   Beuth, Josef ^a   Blackwell, C Caroline ^c   Giersen, Sonja ^b   Higgins, Paul G ^a   Tzanakaki, Georgina ^d   Unverhau, Heike ^a   Weir, Donald M ^e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Meningitis Vaccine   (Germany)

^c Hunter Immunology   (Australia)

^d NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cross reactivity; Endotoxin; Meningococcal disease

Indexed keywords

CARBOHYDRATE ANTIGEN; GLYCOCONJUGATE; LIPOOLIGOSACCHARIDE; PARAGLOBOSIDE;

ADOLESCENT; ADULT; ANTIGEN BINDING; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; CARBOHYDRATE ANALYSIS; COMMENSALISM; CONFERENCE PAPER; CROSS REACTION; DISEASE SEVERITY; EUROPE; GREECE; HUMAN; IMMUNITY; IMMUNOPHENOTYPING; MENINGOCOCCOSIS; MORAXELLA CATARRHALIS; NEISSERIA; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RUSSIAN FEDERATION; UNITED KINGDOM;

EID: 0842303175     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.036     Document Type: Conference Paper

References (75)

1. Mandrell R.E., Griffiss J.M., Macher B.A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med. 168(1):1988;107-126.
2. Jones D.M., Borrow R., Fox A.J., Gray S., Cartwright K.A., Poolman J.T. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb. Pathog. 13:1992;219-224.
3. Abdillahi H., Poolman J.T. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol. 26(3):1988;177-180.
4. Scholten R.J., Kuipers B., Valkenburg H.A., Dankert J., Zollinger W.D., Poolman J.T. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol. 41(4):1994;236-243.
5. Dell A., Azadi P., Tiller P., Thomas-Oates J., Jennings H.J., Beurret M.et al. Analysis of oligosaccharide epitopes of meningococcal lipopolysaccharides by fast-atom-bombardment mass spectrometry. Carbohydr Res. 200:1990;59-76.
6. Gu X.X., Tsai C.M., Karpas A.B. Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis. J Clin Microbiol. 30(8):1992;2047-2203.
7. Jennings H.J., Johnson K.G., Kenne L. The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis. Carbohydr. Res. 121:1983;233-241.
8. Kim J.J., Phillips N.J., Gibson B.W., Griffiss J.M., Yamasaki R. Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes. Infect Immun. 62(5):1994;1566-1575.
9. Kogan G., Uhrin D., Brisson J.R., Jennings H.J. Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes. Carbohydr Res. 298(3):1997;191-199.
10. Michon F., Beurret M., Gamian A., Brisson J.R., Jennings H.J. Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. J. Biol. Chem. 265(13):1990;7243-7247.
11. Pavliak V., Brisson J.R., Michon F., Uhrin D., Jennings H.J. Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis. J. Biol. Chem. 268(19):1993;14146-14152.
12. Plested J.S., Makepeace K., Jennings M.P., Gidney M.A., Lacelle S., Brisson J.et al. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun. 67(10):1999;5417-5426.
13. Rahman M.M., Stephens D.S., Kahler C.M., Glushka J., Carlson R.W. The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent. Carbohydr Res. 307(3-4):1998;311-324.
14. Wakarchuk W., Gilbert M., Martin A., Wu Y., Brisson J.-R., Thibault P.et al. Structure of an α2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1. Eur J Biochem. 254:1998;626-633.
15. Mandrell R.E., Griffiss J.M., Smith H., Cole J.A. Distribution of a lipooligosaccharide-specific sialyltransferase in pathogenic and non-pathogenic Neisseria. Microb. Pathog. 14(4):1993;315-327.
16. Mandrell R.E., Kim J.J., John C.M., Gibson B.W., Sugai J.V., Apicella M.A.et al. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173(9):1991;2823-2832.
17. Mandrell R.E., Apicella M.A. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology. 187(3-5):1993;382-402.
18. Hammerschmidt S., Birkholz C., Zahringer U., Robertson B.D., van Putten J., Ebeling O.et al. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol. 11(5):1994;885-896.
19. McLeod Griffiss J., Brandt B.L., Saunders N.B., Zollinger W. Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes. J Biol Chem. 275(13):2000;9716-9724.
20. Jennings M.P., Srikhanta Y.N., Moxon E.R., Kramer M., Poolman J.T., Kuipers B.et al. The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology. 145(Pt 11):1999;3013-3021.
21. Berrington A.W., Tan Y.C., Srikhanta Y., Kuipers B., van der Ley P., Peak I.R.et al. Phase variation in meningococcal lipooligosaccharide biosynthesis genes. FEMS Immunol Med Microbiol. 34(4):2002;267-275.
22. Varaine F., Caugant D.A., Riou J.Y., Konde M.K., Soga G., Nshimirimana D.et al. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg. 91(1):1997;3-7.
23. Booy R., Kroll J.S. Bacterial meningitis and meningococcal infection. Curr. Opin. Pediatr. 10(1):1998;13-18.
24. Fonkoua M.C. Meningococcal meningitis in Africa. Am J Nurs. 102(12):2002;17.
25. Braun J.M., Blackwell C.C., Poxton I.R., Ahmer O.E., Gordon A.E., Madani O.M.et al. Proinflammatory responses to lipo-oligosaccharide of Neisseria meningitidis immunotype strains in relation to virulence and disease. J. Infect Dis. 185(10):2002;1431-1438.
26. Katial R.K., Brandt B.L., Moran E.E., Marks S., Agnello V., Zollinger W.D. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine. Infect Immun. 70(2):2002;702-707.
27. Saunders N.B., Shoemaker D.R., Brandt B.L., Moran E.E., Larsen T., Zollinger W.D. Related Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun. 67(1):1999;113-119.
28. Prokop O, Uhlenbruck G. Human blood and serum groups. McClaren and Sons, London; 1965.
29. Race RR, Sanger R. Blood groups in man. 6th ed. Backwell Scientific Publications, Oxford; 1975.
30. Hakomori S, Kannagi R. Carbohydrate antigens in higher animals. In: Weir DM, editor. Handbook of experimental immunology. Blackwell Scientific Publications, London; 1986.
31. Bailly P., Piller F., Gillard B., Veyrieres A., Marcus D., Cartron J.P. Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes. Carbohydr. Res. 228(1):1992;277-287.
32. Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 262:1993;114-117.
33. Butch A.W., Nahm M.H. Functional properties of human germinal centre B cells. Cell Immunol. 140(2):1992;331-344.
34. Wiels J., Fellous M., Tursz T. Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci USA. 78(10):1981;6485-6488.
35. Marcus D.M., Naiki M., Kundu S.K. Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes. Proc Natl Acad Sci USA. 73(9):1976;3263-3267.
36. Marsh W.L., Jenkins W.J. Anti-i: a new cold antibody. Nature. 188:1960;753-755.
37. Marsh W.L. Anti-i, a cold antibody defining the Ii relationship in human red cells. Br J Haematol. 7:1961;200-209.
38. Wiener A.S. Blood group distributions. Ann Intern Med. 79(1):1973;137.
39. Kim J.J., Mandrell R.E., Griffiss J.M. Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes. Infect Immun. 57(2):1989;602-608.
40. Griffiss J.M., O'Brien J.P., Yamasaki R., Williams G.D., Rice P.A., Schneider H. Physical heterogeneity of neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infect Immun. 55(8):1987;1792-1800.
41. Griffiss J.M., Schneider H., Mandrell R.E., Jarvis G.A., Kim J.J., Gibson B.et al. The immunochemistry of neisserial LOS. Antonie Van Leeuwenhoek. 53(6):1987;501-507.
42. Tsai C.M., Civin C.I. Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal beta 1-4 GlcNAc beta 1-3 Gal beta 1-4 Glc). Infect Immun. 59(10):1991;3604-3609.
43. Siddiqui B., Hakomori S. A ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum. Biochim Biophys Acta. 330(2):1973;147-155.
44. Holme T., Rahman M., Jansson P.E., Widmalm G. The lipopolysaccharide of Moraxella catarrhalis structural relationships and antigenic properties. Eur. J. Biochem. 265(2):1999;524-529.
45. Schneider H., Hale T.L., Zollinger W.D., Seid R.C. Jr., Hammack C.A., Griffiss J.M. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun. 45(3):1984;544-549.
46. Vaneechoutte M., Verschraegen G., Claeys G., Weise B., Van den Abeele A.M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol. 28(12):1990;2674-2680.
47. Vaneechoutte M., Verschraegen G., Claeys G., Van Den Abeele A.M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol. 28(2):1990;182-187.
48. Rahman M., Jonsson A.B., Holme T. Monoclonal antibodies to the epitope alpha-Gal-(1-4)-beta-Gal-(1-3) of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis. Microb Pathog. 24(5):1998;299-308.
49. Rahman M., Holme T., Jonsson I., Krook A. Human immunoglobulin isotype and IgG subclass response to different antigens of Moraxella catarrhalis. APMIS. 105(3):1997;213-220.
50. Rahman M., Holme T. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J Med Microbiol. 44(5):1996;348-354.
51. Edebrink P., Jansson P.E., Rahman M.M., Widmalm G., Holme T., Rahman M. et al. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res. 257(2):1994;269-284.
52. Edebrink P., Jansson P.E., Rahman M.M., Widmalm G., Holme T., Rahman M. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr Res. 266(2):1995;237-261.
53. Edebrink P., Jansson P.E., Widmalm G., Holme T., Rahman M. The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292. Carbohydr Res. 295:1996;127-146.
54. Masoud H., Perry M.B., Richards J.C. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur. J. Biochem. 220(1):1994;209-216.
55. Jonsson I., Holme T., Krook A., Rahman M., Thoren M. Variability of surface-exposed antigens of different strains of Moraxella catarrhalis. Eur J Clin Microbiol Infect Dis. 11(10):1992;9199-10022.
56. Jonsson I., Holme T., Krook A., Thoren M. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria. Eur J Clin Microbiol Infect Dis. 12(4):1993;289-293.
57. Jonsson I., Holme T., Krook A. Significance of isolation of Moraxella catarrhalis in routine cultures from the respiratory tract in adults: antibody response studied in a whole cell EIA. Scand J. Infect Dis. 26(5):1994;553-558.
58. Kremastinou J., Tzanakaki G., Pagalis A., Theodondou M., Weir D.M., Blackwell C.C. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. FEMS Immunol Med Microbiol. 24(1):1999;73-78.
59. Kremastinou J., Tzanakaki G., Velonakis E., Voyiatzi A., Nickolaou A., Elton R.A.et al. Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens. FEMS Immunol Med Microbiol. 23(1):1999a;13-20.
60. Gold R., Goldschneider I., Lepow M.L., Draper T.F., Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J. Infect Dis. 137(2):1978;112-121.
61. Holten E., Bratlid D., Bovre K. Carriage of Neisseria meningitidis in a semi-isolated arctic community. Scand J Infect Dis. 10(1):1978;36-40.
62. Blakebrough I.S., Greenwood B.M., Whittle H.C., Bradley A.K., Gilles H.M. The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis. 146(5):1982;626-637.
63. Saez-Nieto J.A., Dominguez J.R., Monton J.L., Cristobal P., Fenoll A., Vazquez J.et al. Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain. Hygiene (London). 94(3):1985;279-288.
64. Cartwright K.A., Stuart J.M., Jones D.M., Noah N.D. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 99(3):1987;591-601.
65. Coen P.G., Cartwright K., Stuart J. Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica. Int J Epidemiol. 29(1):2000;180-188.
66. Olsen S.F., Djurhuus B., Rasmussen K., Joensen H.D., Larsen S.O., Zoffman H.et al. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect. 106(3):1991;445-457.
67. Davies A.L., O'Flanagan D., Salmon R.L., Coleman T.J. Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection. Epidemiol Infect. 117(2):1996;259-266.
68. Simmons G., Martin D., Stewart J., Bremner D. Carriage of Neisseria lactamica in a population at high risk of meningococcal disease. Epidemiol Infect. 125(1):2000;99-104.
69. Goldblatt D., Turner M.W., Levinsky R.J. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect Dis. 162(5):1990;1128-1135.
70. Murphy T.F., Bartos L.C. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun. 57(10):1989;2938-2941.
71. Faden H., Waz M.J., Bernstein J.M., Brodsky L., Stanievich J., Ogra P.L. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 100(8):1991;612-615.
72. Harrison L.M., Morris J.A., Telford D.R., Brown S.M., Jones K. The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position. FEMS Immunol Med Microbiol. 25(1-2):1999;19-28.
73. Faden H., Hong J.J., Pahade N. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads. Ann Otol Rhinol Laryngol. 103(7):1994;522-524.
74. Goldschneider I., Gotschlich E.C., Artensen M.S. Human immunity to meningococcus. I. The role of humoral antibodies. J Exp Med. 129:1969;1307-1326.
75. Goldschneider I., Gotschlich E.C., Artensen M.S. Human immunity to meningococcus. II. Development of natural immunity. J Exp Med. 129:1969;1327-1346.